Patent intelligence · US
US 8618080
Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
Patent details — US 8618080
- Jurisdiction
- US
- Status
- granted
- Grant date
- Dec 31, 2013
- Expiration
- Dec 26, 2033
- Applicant
- OM PHARMA
- Claims
- 23
- CPC classes
- A61K, A61K31/16, A61K31/221, A61K31/661
Quick answer
US 8618080 (Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines) is held by OM PHARMA. Status: granted. Granted Dec 31, 2013. Expires Dec 26, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- OM PHARMA
- Grant date
- Expiration
- Claims
- 23
- CPC classes
- A61K, A61K31/16, A61K31/221, A61K31/661, A61K31/6615, A61P
More from OM PHARMA
Related pharmaceutical patents in our USPTO index.
-
US 9198961
Bacterial extract for digestive or urinary tract disorders and process for its preparation
granted -
US 9017743
Bacterial extract for digestive or urinary tract disorders and process for its preparation
granted -
US 8236522
Bacterial extract for digestive or urinary tract disorders and process for its preparation
granted -
US 8173133
Acyl pseudodipeptides which carry a functionalized auxiliary arm
granted -
US 7915240
Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
granted -
US 7799762
Acyl pseudodipeptides which carry a functionalised auxialiary arm
granted -
US 7157092
Acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same
granted
Frequently asked questions
What is US patent 8618080?
US 8618080 (Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines) is held by OM PHARMA. Status: granted. Granted Dec 31, 2013. Expires Dec 26, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8618080?
OM PHARMA is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8 pharmaceutical patents for this assignee.
When does US 8618080 expire?
Our index shows an expiration date of Dec 26, 2033 (7 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.